58379-80-9Relevant articles and documents
INHIBITOR COMPOUNDS
-
Page/Page column 63; 138-140, (2021/01/29)
The disclosure relates to heterocyclic compounds and methods for their preparation. The disclosure provides compounds that may have beneficial therapeutic activity in the treatment of a disease or condition mediated by excessive or otherwise undesirable Des1 and/or fibrotic activity.
ATR INHIBITOR AND APPLICATION THEREOF
-
Paragraph 0156; 0157, (2020/12/29)
Disclosed are a compound as an ATR inhibitor and an application in preparing a drug as an ATR inhibitor. In particular, disclosed is a compound represented by formula (I) or an isomer or pharmaceutically acceptable salt thereof.
Pd(II)-Catalyzed [4 + 2] Heterocyclization Sequence for Polyheterocycle Generation
Glaisyer, Elizabeth L.,Watt, Michael S.,Booker-Milburn, Kevin I.
supporting information, p. 5877 - 5880 (2018/09/25)
A new Pd(II)-catalyzed cascade sequence for the formation of polyheterocycles, from simple starting materials, is reported. The sequence is applicable to both indole and pyrrole substrates, and a range of substituents are tolerated. The reaction is thought to proceed by a Pd(II)-catalyzed C-H activated Heck reaction followed by a second Pd(II)-catalyzed aza-Wacker reaction with two Cu(II)-mediated Pd(0) turnovers per sequence. The sequence can be considered a formal [4 + 2] heterocyclization.